32 ACTIVATION OF REDOX-SENSITIVE INFLAMMASOMES UNDERLIES THE BIOLOGICAL PHENOTYPE OF MYELODYSPLASTIC SYNDROMES

Miho Shiratori‐Hayashi, K. Koga, Hidetoshi Tozaki‐Saitoh, Yuta Kohro, Honami Toyonaga, Yamaguchi Chiharu, Ayumi Hasegawa, Takeshi Nakahara, Junichi Hachisuka, Akira Shizuo, Hideyuki Okano, Masutaka Furue, Kazuhide Inoue, Makoto Tsuda

Nature Medicine

Chapter in a book1985

SOME PROPERTIES OF O(32) SUPERSTRINGS

Edward Witten

Article2013

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

Rebecca C. Coll, Luke O'neill

PLoS ONE

32 ACTIVATION OF REDOX-SENSITIVE INFLAMMASOMES UNDERLIES THE BIOLOGICAL PHENOTYPE OF MYELODYSPLASTIC SYNDROMES

Abstract

Discussion(0)

Related publications

Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes

Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs

STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch

SOME PROPERTIES OF O(32) SUPERSTRINGS

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes